Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells

s / Biol Blood Marrow Transplant 19 (2013) S178eS193 S191 herpetic neuralgia (n1⁄45), severe pain (n1⁄43), scarring (n1⁄41), and motor weakness (n1⁄41); 2 patients required hospitalization and 3 patients developed disseminated zoster. Conclusions: Our limited retrospective analysis suggests a significant reduction in rates of post auto-HCT rates of VZV infection with extended 12month antiviral prophylaxis. VZV infection is a significant complication post auto-HCT, and extended prophylaxis appears to be safe and effective in this setting.